Literature DB >> 26730331

The vasodilatory action of telmisartan on isolated mesenteric artery rings from rats.

Xiao-Ping Chen1, Li-Ren Qian1.   

Abstract

OBJECTIVES: Angiotensin II type 1 receptor blockers (ARBs) represent one of the widely used antihypertensive agents. In addition to anti-hypertension effect, some ARBs also show other molecular effects such as activating peroxisome proliferator-activated receptor-γ and so on. Here we studied the effects of telmisartan on the rat isolated mesenteric artery rings pre-contracted by phenylephrine (PE).
MATERIALS AND METHODS: Rat mesenteric artery rings were pre-contracted with 10 μM PE, and cumulative concentration-response curves to telmisartan were obtained. The endothelium-dependent mechanisms were investigated by mechanical removal of the endothelium. K(+) channels were investigated by pretreatment of the artery rings with various K(+) channel blockers.
RESULTS: Telmisartan produced concentration-dependent relaxation of the artery rings pre-contracted by 10 μM PE. Denudation of the endothelium did not affect the relaxant effect of telmisartan. Pretreatment with BaCl2 nearly inhibited the relaxation induced by the 0.5, 1, 5 and 10 μM telmisartan, but did not affect the relaxation induced by the 50 and 100 μM telmisartan. While the relaxation induced by telmisartan was not affected by pretreatment with TEA, 4-AP and glibenclamide.
CONCLUSION: These findings demonstrated that telmisartan produces concentration dependent vasodilation in isolated rat mesenteric artery rings with or without endothelium pre-contracted by PE. KIR channel may be involved in such a relaxant effect of telmisartan.

Entities:  

Keywords:  ARB; Mesenteric arteries; Potassium channel; Rat; Telmisartan; Vasodilation

Year:  2015        PMID: 26730331      PMCID: PMC4686581     

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


Introduction

Angiotensin II is the major effector of the renin-angiotensin-aldosterone system, which takes effect through angiotensin II type 1 and type 2 receptors (AT1 and AT2). AT1 mediates most of the well-known pathophysiological effects, which lead to hypertension, insulin resistance and so on (1, 2). The angiotensin II type 1 receptor blockers (ARBs), which competitively bind AT1 antagonist with angiotensin II have been recommended to lower blood pressure and prevent cardiovascular and kidney diseases by many guidelines. The blood pressure reducing effect of ARBs is obtained from the systemic vasodilation which is the result of antagonist with angiotensin II. In addition, several basic experimental studies showed that some ARBs have specific molecular effects such as decreasing basal MCP-1 levels in human monocytes by irbesartan and losartan (3) and inducing adiponectin in adipocytes by irbesartan (4). Telmisartan is the long-acting ARB (5) and has been used clinically worldwide. Other than the classical anti-hypertensive effect through binding AT1 receptor, telmisartan also shows molecular effects such as activating peroxisome proliferator-activated receptor-γ (6), stimulating CYP11B2 expression in human adrenal H295R cells (7), blocking hKv1.5 potassium channels, which were expressed on Xenopus laevis oocytes (8), and stimulating adiponectin protein expression (4, 9). The above effects were obtained in the absence of angiotensin II, which suggested that an AT1 receptor independent mechanism of action may be involved. It is a common knowledge that telmisartan can reduce blood pressure through its vascular vasodilatory effect in vivo. However, it remains unclear whether telmisartan has dilatory action on isolated small artery rings in vitro in the absence of angiotensin II. In this study, we tested the hypothesis that telmisartan can dilate the rat isolated mesenteric artery rings.

Materials and Methods

This study was performed with the permission of the Ethics Committee of the Navy General Hospital of PLA, three month old WKY rats weighing 250–260 g were used. The rats were housed under a 12-hr/12-hr day/night cycle and given tap water and standard chow ad libitum.

Dissociation of rat mesenteric artery ring

At the beginning of the study, rats were decapitated and the mesenteric vessels of the small intestine were removed and placed in cold (4 °C) physiological salt solution (PSS) which was oxygenated (95% O2, 5% CO2). The composition of PSS was as follows (in mmol/L): KCl 4.7, NaCl 119.0, NaHCO3 25.0, KH2PO4 0.4, MgSO4 1.17, CaCl2 2.5, and glucose 5.5. The fat and connective tissues surrounding the second-order mesenteric arterioles were removed; each artery was cut into cylindrical segments, which was 2.5 mm in length. The inner diameter of the arterial rings ranged from 100 to 150 μm.

Record of vascular tone

According to the method described by Huang et al (10), arterial rings isolated from rats were placed in a multi-myograph system (Danish Myo Technology A/S), and changes of the tension of the vessel were recorded by Power lab data recording system (AD Instrument). The arterial rings were bathed in PSS solution, which was changed every 20 min, with 95% O2 plus 5% CO2 at 37 °C (pH 7.40). The arterial rings were mounted under an optimal resting tension. This optimal resting tension was the minimum level of stretch that gave the largest force after administration of 60 mM KCl. The rings were allowed to stabilize at optimal resting tension for 90 min before the start of the experiments.

Effect of telmisartan on contractions induced by phenylephrine (PE)

After 90 min of stabilization, intact endothelium mesenteric artery ring was pre-contracted with PE (10 μM). Cumulative concentration-response curves to 0.5, 1, 5, 50, and 100 μM telmisartan (TM) were recorded. Relaxing responses were measured as percentages of the contraction induced by PE. The curves of concentration response to DMSO, which is the solvent of telmisartan, were also obtained in endothelium-intact mesenteric arterial rings.

Role of endothelium in telmisartan-induced relaxation

In order to examine the role of endothelium involvement in telmisartan-mediated relaxation, response to telmisartan was studied in endothelium-intact and endothelium-denuded rings pre-contracted by PE (10 μM). At the end of relaxation, 60 mM KCl was added into the slot to test the activity of arterial rings and to study the role of depolarization in such relaxation. The presence of functional endothelium was assessed by the ability of acetylcholine (ACh, 10 μM) to induce more than 90% relaxation of pre-contracted rings with PE (10 μM) and the absence, less than 10% of relaxation induced by ACh.

Role of K+ channels in telmisartan vasodilation

To examine the role of K+ channels in vasodilation, the endothelium-intact ring was used for this determination by preincubation with one of the following K+ channel blockers: 10 mM tetraethyl-ammonium (TEA), 1 mM 4-amino-pyridine (4-AP), 10 μM glibenclamide (Gli), and 30 μM BaCl2 for 30 min before PE (10 μM) pre-contracted. Then, the cumulative concentration response of telmisartan at the concentrations of 0.5, 1, 5, 50, and 100 μM was directly added.

Statistical analysis

Data are presented as the mean ± SEM, and n stands for the number of rings prepared from different rats. The curves of concentration response to telmisartan were based on the percent relaxation of the PE-induced contraction. The results were analyzed by Student’s t-test. Two-sided P<0.05 was considered statistically significant.

Results

Effect of telmisartan on PE-induced contractions

The contraction induced by 10 μM PE in rat mesenteric artery rings was 20.41±3.36 mN. Telmisartan 0.5, 1, 5, 50 and, 100 μM concentration dependently relaxed the pre-contractions with the maximum relaxation being 100% for 10 μM PE-induced contractions. Endothelium-denudation did not affect the relaxant effect of telmisartan. In contrast, DMSO did not affect the contractions induced by PE. 100 μM telmisartan relaxed the contractions induced by 10 μM PE completely. At the end of relaxations, 60 mM KCl was added into the slot, which induced 16.25±2.73 mN contractions of the mesenteric artery rings again (Figure 1).
Figure 1

Relaxation effect of telmisartan (TM, 0.5, 1, 5, 50, and 100 μM) on pre-contractions induced by 10 μM phenylephrine (PE) in rat isolated mesenteric artery rings with an intact or denuded endothelium. Telmisartan 0.5, 1, 5, 10, 50, and 100 μM concentration dependently relaxed the pre-contractions with the maximum relaxation being 100% for 10 μM PE-induced contractions. Denudation of the endothelium did not affect the relaxant effect of telmisartan. In contrast, the vehicle of DMSO did not affect the contractions induced by PE (A). 100 μM of telmisartan relaxed the contractions induced by 10 μM PE completely. Until a stable tone plateau was reached, 60 mM of KCl was added, which induced 16.25±2.73 mN contractions of the artery rings again (B). Each point represents the mean±SEM for 6 artery rings obtained from separate rats. **P<0.01 vs TM and TM-denude

Relaxation effect of telmisartan (TM, 0.5, 1, 5, 50, and 100 μM) on pre-contractions induced by 10 μM phenylephrine (PE) in rat isolated mesenteric artery rings with an intact or denuded endothelium. Telmisartan 0.5, 1, 5, 10, 50, and 100 μM concentration dependently relaxed the pre-contractions with the maximum relaxation being 100% for 10 μM PE-induced contractions. Denudation of the endothelium did not affect the relaxant effect of telmisartan. In contrast, the vehicle of DMSO did not affect the contractions induced by PE (A). 100 μM of telmisartan relaxed the contractions induced by 10 μM PE completely. Until a stable tone plateau was reached, 60 mM of KCl was added, which induced 16.25±2.73 mN contractions of the artery rings again (B). Each point represents the mean±SEM for 6 artery rings obtained from separate rats. **P<0.01 vs TM and TM-denude

Role of K+ channels on telmisartan induced relaxation

After pre-incubation with TEA (10 mM), 4-AP (1 mM), Gli (10 μM), and BaCl2 (30 μM) for 30 min, the tensions induced by 10 μM PE were 19.43±2.76 mN, 22.53±3.12 mN, 21.72±4.26 mN, and 18.54±3.79 mN in isolated arterial rings, respectively. Pretreatment with BaCl2 nearly inhibited the relaxation induced by the 0.5, 1, 5, and 10 μM concentration of telmisartan, but BaCl2 did not affect the relaxation induced by the 50 and 100 μM telmisartan. While the relaxation induced by telmisartan was not affected by pretreatment with TEA, 4-AP and Gli (Figure 2).
Figure 2

Role of K+ channels on the relaxation induced by telmisartan (TM, 0.5, 1, 5, 10, 50, and 100 μM) in rat mesenteric artery rings pre-contracted with 10 μM phenylephrine (PE). After pre-incubation with tetraethylammonium (TEA, 10 mM), 1 mM 4-aminopyridine (4-AP), 10 μM glibenclamide (Gli) and 30 μM BaCl2 for 30 min, the tension induced by 10 μM PE were 19.43±2.76 mN, 22.53±3.12 mN, 21.72±4.26 mN and 18.54±3.79 mN in rat mesenteric artery rings, respectively. Pretreatment with BaCl2 nearly inhibited the relaxation induced by the 0.5, 1, 5 and 10 μM concentration of telmisartan, but did not affect the relaxation induced by the 50 and 100 μM telmisartan. While the relaxation induced by telmisartan were not affected by pretreatment with TEA, 4-AP and glibenclamide. Each point represents the mean± SEM for 6 mesenteric artery rings obtained from separate rats. * P<0.05, **P<0.01 vs TEA, Gli and 4-AP groups

Role of K+ channels on the relaxation induced by telmisartan (TM, 0.5, 1, 5, 10, 50, and 100 μM) in rat mesenteric artery rings pre-contracted with 10 μM phenylephrine (PE). After pre-incubation with tetraethylammonium (TEA, 10 mM), 1 mM 4-aminopyridine (4-AP), 10 μM glibenclamide (Gli) and 30 μM BaCl2 for 30 min, the tension induced by 10 μM PE were 19.43±2.76 mN, 22.53±3.12 mN, 21.72±4.26 mN and 18.54±3.79 mN in rat mesenteric artery rings, respectively. Pretreatment with BaCl2 nearly inhibited the relaxation induced by the 0.5, 1, 5 and 10 μM concentration of telmisartan, but did not affect the relaxation induced by the 50 and 100 μM telmisartan. While the relaxation induced by telmisartan were not affected by pretreatment with TEA, 4-AP and glibenclamide. Each point represents the mean± SEM for 6 mesenteric artery rings obtained from separate rats. * P<0.05, **P<0.01 vs TEA, Gli and 4-AP groups

Discussion

Since 1970s, the deleterious effects of angiotensin II on the cardiovascular and renal systems have been recognized (11, 12), making the blockade of the renin-angiotensin system an effective therapeutic approach in the treatment of hypertension, chronic renal dysfunction, cardiac insufficiency, and so on. ARBs, which exhibit highly selective binding and antagonistic activity for the AT1 receptor, have become a major drug class in the treatment of cardiovascular and renal disease (13). The effects of ARBs are due to the antagonistic effect, which diminishes the harmful role of angiotensin II in vivo, however, more and more studies have shown that in addition to their AT1 receptor blocking activity, some ARBs may also activate peroxisome proliferator-activated receptor γ and affect currents through various ion channels expressed in cells (14) in vitro. Telmisartan exhibits inhibition effect on several ion channels, such as cloned Kv 1.3 and Kv 1.5 voltage-gated potassium channels expressed in X. Laevis oocytes (8, 15), Kv 1.3 expressed in rat lymphocytes (16), and HERG channels expressed in X. Laevis oocytes (8). However, such effects were typically observed at high concentrations in micromolar range. Our present study found that telmisartan can relax the rat isolated mesenteric artery rings which were precontracted with PE. Such a phenomenon may not be associated with angiotensin II, for it was observed in vitro. Next, we further investigated the probable mechanisms involved in the telmisartan induced rat mesenteric artery ring relaxation. To our knowledge, endothelium dependent or independent mechanism was involved in vascular relaxation. In the endothelium dependent mechanism, the intact endothelium cells secrete vascular dilators such as nitric oxide, prostacyclin and hyperpolarizing factor (17, 18). The present study showed that telmisartan induced vasodilation in the isolated endothelium-denuded rat mesenteric artery rings was not significantly different as compared with that in the endothelium intact artery rings. Such results suggest that telmisartan has an endothelium independent vasodilatory effect on the isolated rat mesenteric artery. The increasing potassium efflux through membrane K+ channels, blocking of extracellular Ca2+ influx through membrane Ca2+ channels, as well as other mechanisms participate in the process of endothelium independent vasodilation (19). Up to now, four K+ channels have been found in vascular smooth muscle cells, which include ATP-sensitive (KATP), calcium-activated (BKCa), delayed rectifier (KV), and inward rectifier (KIR) potassium channels (20). Potassium ion efflux induced by activating the above K+ channels leads to hyperpolarization of the vascular muscle cell membrane, inhibits calcium ion influx through voltage-operative Ca2+ channel and causes vascular dilation. In order to investigate the role of K+ channels in the telmisartan induced vasodilation in rat mesenteric artery rings, we used selective blocker of K+ channels to pretreat rat mesenteric artery rings. We observed that the relaxant effect of telmisartan in the pre-contracted mesenteric artery rings was not affected by pretreatment with 10 mM TEA, 10 μM Gli and 1 mM 4-AP, which are the selective blockers of BKCa, KATP and KV channels, respectively. But 30 μM BaCl2, a selective blocker of inward rectifier potassium channels (KIR), significantly inhibited the vasodilation induced by 0.5, 1, 5 and, 10 μM telmisartan, which indicated that KIR channels may play a role in the vasodilation of telmisartan. With the increase of telmisartan concentration, a counter result has been observed: 50 μM and 100 μM telmisartan can reverse the inhibited effect of BaCl2. This result may be explained by the possibilities that telmisartan competes with BaCl2 to act on KIR channels or telmisartan may act in other ion channels. After telmisartan completely dilated the PE induced pre-contraction of rat mesenteric artery rings, 60 mM KCl can significantly make the dilated artery rings re-contracted, considering the vascular contracting effect of 60 mM KCl is related with voltage-operative Ca2+ channel (21), the result indicates that voltage-operative Ca2+ channel is not involved in the vascular relaxant effect of telmisartan.

Conclusion

The present study demonstrated for the first time that telmisartan produces concentration dependent vasodilation in isolated rat mesenteric artery rings with or without endothelium pre-contracted by PE. KIR channel may be involved in this relaxant effect of telmisartan. Our research only observed the relaxant effect of telmisartan in the isolated rat mesenteric artery rings in vitro and the maximum plasma concentration of telmisartan was 0.04 to 1.15 µM after daily oral 20 mg to 120 mg administration (5). Whether such concentrations of telmisartan in plasma also play a role in vasodilation in rat mesenteric artery in vivo need to be further investigated. However, the effects of ARBs on ion channels typically occur at the supratherapeutic concentrations in micromolar range; clinical symptoms associated with such effects of ARBs have not been reported.
  21 in total

1.  [Effects of telmisartan on 4-Aminopyridine-sensitive voltage dependant potassium channel of lymphocyte derived from spontaneously hypertensive rat].

Authors:  Jian Luo; Ke-Tao Ma; Yuan-Ming Zhang; Jun-Qiang Si; Ping Liang; Jing Li
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2010-08

2.  Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1.

Authors:  Julie M Proudfoot; Kevin D Croft; Ian B Puddey; Lawrence J Beilin
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

3.  Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

Authors:  H Gavras; A F Lever; J J Brown; R F Macadam; J I Robertson
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

4.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

5.  Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells.

Authors:  Ken Matsuda; Akira Uruno; Naotaka Kogure; Kaori Sugawara; Hiroki Shimada; Masahiro Nezu; Takako Saito-Ito; Yuko Iki; Masataka Kudo; Kyoko Shimizu; Ikuko Sato; Takeo Yoshikawa; Fumitoshi Satoh; Ryo Ito; Atsushi Yokoyama; William E Rainey; Akiko Saito-Hakoda; Sadayoshi Ito; Akira Sugawara
Journal:  Mol Cell Endocrinol       Date:  2013-12-12       Impact factor: 4.102

Review 6.  Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.

Authors:  Carlos M Ferrario; William B Strawn
Journal:  Am J Cardiol       Date:  2006-05-09       Impact factor: 2.778

7.  Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.

Authors:  J Stangier; C A Su; W Roth
Journal:  J Int Med Res       Date:  2000 Jul-Aug       Impact factor: 1.671

Review 8.  Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.

Authors:  Jane A Mitchell; Ferhana Ali; Lucy Bailey; Laura Moreno; Louise S Harrington
Journal:  Exp Physiol       Date:  2007-10-26       Impact factor: 2.969

Review 9.  Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.

Authors:  T Nagao; P M Vanhoutte
Journal:  Am J Respir Cell Mol Biol       Date:  1993-01       Impact factor: 6.914

10.  Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro.

Authors:  Satoru Yamada; Natsuko Ano; Kyoko Toda; Akira Kitaoka; Kaoru Shiono; Gaku Inoue; Koichiro Atsuda; Junichiro Irie
Journal:  Hypertens Res       Date:  2008-04       Impact factor: 3.872

View more
  1 in total

1.  Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.

Authors:  Wanyu Wang; Ailing Song; Yiming Zeng; Xiaoyang Chen; Yixiang Zhang; Yonghong Shi; Yihua Lin; Wen Luo
Journal:  BMC Cardiovasc Disord       Date:  2018-07-03       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.